Skip to main content

Mark Meyers, Mary Holland

Premium

EraGen Biosciences has hired Mark Meyers and Mary Holland as vice presidents of sales and marketing. In his new position, Meyers will build partnerships around EraGen’s Master Catalog platform, an interpretive proteomics system based on an evolutionary analysis of protein families. It can be used to determine model organisms and for drug target identification. Before joining EraGen, Meyers was vice president of sales for Scimagix.

Meantime, in her new position, Holland will be responsible for EraGen’s Aegis synthetic DNA platform. Before joining EraGen, Holland was the senior director of worldwide corporate accounts for Nanogen.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.